Biotech · Private company
TaiMed Biologics Inc.
Track this companyFree. Adds TaiMed Biologics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- ibalizumabPhase 3 · HIVClinicalTrials.gov · fetched Nov 12, 2026
- ibalizumab-uiykPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
- Optimized Background RegimenPhase 3 · HIVClinicalTrials.gov · fetched Nov 12, 2026
- Optimized Background Regimen (OBR)Phase 3 · HIVClinicalTrials.gov · fetched Nov 12, 2026
- Baseline ARTPhase 2 · HIV -1 InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TMB-365Phase 2 · HIV -1 InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TMB-365/TMB-380Phase 2 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
- TMB-380Phase 2 · HIV -1 InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TMB-607Phase 1 · Human Immunodeficiency VirusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies StudyPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 16, 2025ClinicalTrials.gov NCT07215468 · fetched Nov 12, 2026
- TMB-365 and TMB-380 in Suppressed HIV-1 Infected IndividualsPHASE1_PHASE2 · COMPLETED · started Jul 5, 2022ClinicalTrials.gov NCT05275998 · fetched Nov 12, 2026
- Dose Escalation Safety Study of TMB-365 in HIV-1 Infected ParticipantsPHASE1 · COMPLETED · started Dec 14, 2019ClinicalTrials.gov NCT04027387 · fetched Nov 12, 2026
- Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular InjectionPHASE3 · COMPLETED · started May 30, 2019ClinicalTrials.gov NCT03913195 · fetched Nov 12, 2026
- Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative VolunteersPHASE1 · TERMINATED · started Nov 21, 2016ClinicalTrials.gov NCT03110549 · fetched Nov 12, 2026
- Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1PHASE3 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02707861 · fetched Nov 12, 2026
- Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIVPHASE3 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02475629 · fetched Nov 12, 2026